Shengyun Huang

Dr. Shengyun Huang


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2024 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
LZLianyu Zhao
Lianyu Zhao
SJSong Jin
Song Jin
SWShengyao Wang
Shengyao Wang
ZZZhe Zhang
Zhe Zhang
XWXuan Wang
Xuan Wang
HWHaiwei Wu
Haiwei Wu
Tertiary lymphoid structures (TLSs) are defined as lymphoid aggregates formed in non-hematopoietic organs under pathological conditions. Similar to secondary lymphoid organs (SLOs), the formation of TLSs relies on the interaction between lymphoid tissue inducer (LTi) cells and lymphoid tissue organizer (LTo) cells, involving multiple cytokines. Heterogeneity is a distinguishing feature of TLSs, which may lead to differences in their functions. Growing evidence suggests that TLSs are associated with various diseases, such as cancers, autoimmune diseases, transplant rejection, chronic inflammation, infection, and even ageing. However, the detailed mechanisms behind these clinical associations are not yet fully understood. The mechanisms by which TLS maturation and localization affect immune function are also unclear. Therefore, it is necessary to enhance the understanding of TLS development and function at the cellular and molecular level, which may allow us to utilize them to improve the immune microenvironment. In this review, we delve into the composition, formation mechanism, associations with diseases, and potential therapeutic applications of TLSs. Furthermore, we discuss the therapeutic implications of TLSs, such as their role as markers of therapeutic response and prognosis. Finally, we summarize various methods for detecting and targeting TLSs. Overall, we provide a comprehensive understanding of TLSs and aim to develop more effective therapeutic strategies.

11 April 2021 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
ZLZhenxing Liu
Zhenxing Liu
HWHaiwei Wu
Haiwei Wu
SHShengyun Huang
Shengyun Huang
Wound healing is an important and complicated process that includes four highly integrated and overlapping phases, haemostasis, inflammation, proliferation and tissue remodelling. Nerve growth factor (NGF) was the first member of a family of neurotrophic factors to be discovered, and is an essential neurotrophic factor for the development and maintenance of the central and peripheral nervous systems. Several studies have proposed that NGF and its receptors, tropomyosin‑related kinase receptor 1 and NGF receptor, are involved in the wound healing process, and are important components of the healing of several wounds both in vivo and in vitro. Topical application of NGF significantly promotes the healing of different types of wounds, including diabetic foot ulcers, pressure ulcers and corneal wounds. The present review summarizes the status of NGF and its receptors in current literature, and discusses data obtained in the last few years on the healing action of NGF in cutaneous, corneal and oral wounds.

4 March 2020 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
HZHanchuang Zhu
Hanchuang Zhu
CLCaiyun Liu
Caiyun Liu
CLChangxu Liang
Changxu Liang
BTBin Tian
Bin Tian
HZHanming Zhang
Hanming Zhang
BZBaocun Zhu
Baocun Zhu
A new phenylsulfonamide-based Golgi-targeting fluorescent probe for imaging H 2 S in living cells and zebrafish was reasonably constructed.

6 January 2020 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
XZXue Zhang
Xue Zhang
CLCaiyun Liu
Caiyun Liu
YCYanan Chen
Yanan Chen
XCXinyu Cai
Xinyu Cai
WSWenlong Sheng
Wenlong Sheng
BZBaocun Zhu
Baocun Zhu
A novel Golgi-targeting Cys-specific fluorescent probe (Gol-Cys) was synthesized. Probe Gol-Cys is not only sufficiently sensitive to native Cys in living cells and zebrafish, but also can be used for monitoring the Cys level during Golgi stress.

6 April 2020 in Regenerative Biomaterials
Verified
Journal Article
Open access
YDYan Dai
Yan Dai
XHXiao-Hui Han
Xiao-Hui Han
LHLi-Hua Hu
Li-Hua Hu
HWHai-Wei Wu
Hai-Wei Wu
SHShengyun Huang
Shengyun Huang
YLYu-peng Lu
Yu-peng Lu
To evaluate the clinical efficacy of concentrated growth factors (CGFs) combined with mineralized collagen (MC) in guided bone regeneration (GBR). A retrospective study involving 29 patients treated with GBR technique, which was performed either CGF and MC complexes or MC alone. Implants were inserted simultaneously and cone-beam computed tomography was taken immediately, at 3 and 6 months postoperation. Questionnaires were completed by all patients so as to evaluate the main symptoms and daily activities during the first week after surgery. The outcomes of the two groups were statistically compared. All implants healed uneventfully. Patients in both groups suffered from different levels of discomfort for the reason of swelling, pain and chewing impairment on 1–2 days. Meanwhile, swelling of the Trial group was weaker than the Control group. When compared with the Control group, pain levels in Trial group were more rapidly reduced and patients took fewer analgesics from Day 3. Furthermore, the reconstitution mean value of the graft was thicker at 3 and 6 months in Trial group. CGFs complex with MC were beneficial to relieve the clinical symptoms, promote the peri-implant bone regeneration and shorten the healing time.

1 April 2020 in Acta Biomaterialia
Verified
Journal Article
Closed access
HWHaiwei Wu
Haiwei Wu
XWXuan Wang
Xuan Wang
HLHao Liang
Hao Liang
JZJiawei Zheng
Jiawei Zheng
SHShengyun Huang
Shengyun Huang
DZDongsheng Zhang
Dongsheng Zhang